State Street’s Cyclerion Therapeutics CYCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,771
Closed -$50.1K 4688
2023
Q1
$50.1K Hold
5,771
﹤0.01% 4502
2022
Q4
$75.7K Hold
5,771
﹤0.01% 4448
2022
Q3
$99K Hold
5,771
﹤0.01% 4467
2022
Q2
$63K Sell
5,771
-6
-0.1% -$65 ﹤0.01% 4673
2022
Q1
$128K Buy
5,777
+236
+4% +$5.23K ﹤0.01% 4558
2021
Q4
$191K Buy
5,541
+1,055
+24% +$36.4K ﹤0.01% 4373
2021
Q3
$275K Buy
4,486
+320
+8% +$19.6K ﹤0.01% 4233
2021
Q2
$325K Sell
4,166
-15,841
-79% -$1.24M ﹤0.01% 4022
2021
Q1
$1.12M Sell
20,007
-1,358
-6% -$75.8K ﹤0.01% 3599
2020
Q4
$1.31M Sell
21,365
-589
-3% -$36.1K ﹤0.01% 3508
2020
Q3
$2.67M Sell
21,954
-3,050
-12% -$371K ﹤0.01% 3084
2020
Q2
$2.96M Sell
25,004
-1,862
-7% -$220K ﹤0.01% 3020
2020
Q1
$1.42M Buy
26,866
+533
+2% +$28.3K ﹤0.01% 3199
2019
Q4
$1.43M Buy
26,333
+3,682
+16% +$200K ﹤0.01% 3341
2019
Q3
$5.49M Buy
22,651
+1,294
+6% +$314K ﹤0.01% 2739
2019
Q2
$4.89M Buy
+21,357
New +$4.89M ﹤0.01% 2832